Corline Biomedical AB (OSTO:CLBIO) E10: kr-0.51 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CLBIO Corline Biomedical AB OSTO:CLBIO
43 GF Score
Price kr17.55
GF Value kr4.90
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Corline Biomedical AB E10?

Corline Biomedical AB OSTO:CLBIO -1.68% 43 E10 is kr-0.51 as of Mar. 2026. GuruFocus rates OSTO:CLBIO with a GF Score™ of 43/100 and a GF Value™ of kr4.90 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Corline Biomedical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-0.51 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-19), Corline Biomedical AB's current stock price is kr17.55. Corline Biomedical AB's E10 for the quarter that ended in Mar. 2026 was kr-0.51. Corline Biomedical AB's Shiller PE Ratio of today is .


Corline Biomedical AB  (OSTO:CLBIO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Corline Biomedical AB E10 Related Terms


Corline Biomedical AB E10 Historical Data

* Premium members only.

The historical data trend for Corline Biomedical AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corline Biomedical AB E10 Chart

Corline Biomedical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.47 -0.54 -0.52

Corline Biomedical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.54 -0.53 -0.53 -0.52 -0.51

OSTO:CLBIO vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Corline Biomedical AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corline Biomedical AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Shiller PE Ratio falls into.


OSTO:CLBIO
43GF Score
Corline Biomedical AB OSTO:CLBIO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corline Biomedical AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Corline Biomedical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.1/133.5600*133.5600
=-0.100

Current CPI (Mar. 2026) = 133.5600.

Corline Biomedical AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.049 101.019 -0.065
201609 -0.097 101.138 -0.128
201612 -0.117 102.022 -0.153
201703 -0.233 102.022 -0.305
201706 -0.156 102.752 -0.203
201709 -0.078 103.279 -0.101
201712 -0.107 103.793 -0.138
201803 -0.117 103.962 -0.150
201806 -0.126 104.875 -0.160
201809 -0.088 105.679 -0.111
201812 -0.107 105.912 -0.135
201903 -0.185 105.886 -0.233
201906 -0.156 106.742 -0.195
201909 -0.117 107.214 -0.146
201912 -0.126 107.766 -0.156
202003 -0.150 106.563 -0.188
202006 -0.150 107.498 -0.186
202009 -0.130 107.635 -0.161
202012 -0.010 108.296 -0.012
202103 -0.080 108.360 -0.099
202106 -0.100 108.928 -0.123
202109 -0.100 110.338 -0.121
202112 -0.060 112.486 -0.071
202203 -0.040 114.825 -0.047
202206 0.040 118.384 0.045
202209 0.090 122.296 0.098
202212 0.020 126.365 0.021
202303 0.050 127.042 0.053
202306 -0.110 129.407 -0.114
202309 0.010 130.224 0.010
202312 -0.030 131.912 -0.030
202403 -0.080 132.205 -0.081
202406 -0.200 132.716 -0.201
202409 -0.140 132.304 -0.141
202412 -0.620 132.987 -0.623
202503 -0.130 132.825 -0.131
202506 -0.130 133.699 -0.130
202509 -0.140 133.480 -0.140
202512 -0.200 133.390 -0.200
202603 -0.100 133.560 -0.100

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-0.51 mean?
Corline Biomedical AB (OSTO:CLBIO) has a E10 of kr-0.51 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Corline Biomedical AB and its competitors.
Is Corline Biomedical AB's E10 too high?
Corline Biomedical AB's current E10 is kr-0.51. Overall, Corline Biomedical AB has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Corline Biomedical AB's E10 compare to VRTX and REGN?
Corline Biomedical AB's E10 of kr-0.51 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Corline Biomedical AB and its competitors. Corline Biomedical AB's current E10 is kr-0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corline Biomedical AB stock overvalued right now?
Based on GuruFocus' analysis, Corline Biomedical AB (OSTO:CLBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr4.90, compared to a current price of kr17.55 — trading 258.2% above its estimated fair value. The current E10 is kr-0.51. Corline Biomedical AB's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Corline Biomedical AB (OSTO:CLBIO), the current E10 is kr-0.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Corline Biomedical AB (OSTO:CLBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Corline Biomedical AB stock appears to be overvalued. The current stock price of kr17.55 is trading 258.2% above its estimated GF Value™ of kr4.90. GuruFocus considers Corline Biomedical AB to be Significantly Overvalued.

Key valuation signals for OSTO:CLBIO:

  • E10: kr-0.51
  • GF Value™: kr4.90 vs. price of kr17.55 (258.2% above fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the OSTO:CLBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Corline Biomedical AB Business Description

Address Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB offers customers in the medical technology industry and regenerative medicine as well as transplant clinics products to manage immune thrombosis. The company offers a proprietary surface treatment technology, Corline Heparin Surface (CHS), which can be used in combination with all commonly used implant materials such as polymers (plastics) and various metals, but also for equipment where blood circulation occurs outside the body.
43GF Score

Get the complete analysis for OSTO:CLBIO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.55
Price
kr4.90
GF Value